Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Cancer Research|December 28, 2020
Targeting p300/CBP Attenuates Hepatocellular Carcinoma Progression through Epigenetic Regulation of MetabolismLing-Yan Cai, Shi-Jie Chen, Sen-Hao Xiao, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 23, 2019
AAV9 Edits Muscle Stem Cells in Normal and Dystrophic Adult MiceMichael E Nance, Ruicheng Shi, Chady H Hakim, et al.
Computational and Structural Biotechnology Journal|November 24, 2022
Biomotors, viral assembly, and RNA nanobiotechnology: Current achievements and future directionsLewis Rolband, Damian Beasock, Yang Wang, et al.
Signal Transduction and Targeted Therapy|April 23, 2024
SRY-Box transcription factor 9 triggers YAP nuclear entry via direct interaction in tumorsHui Qian, Chen-Hong Ding, Fang Liu, et al.
JCI Insight|December 7, 2018
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic miceChady H Hakim, Nalinda B Wasala, Christopher E Nelson, et al.
Acta Pharmacologica Sinica|November 26, 2020
Crystallography-guided discovery of carbazole-based retinoic acid-related orphan receptor gamma-t (RORγt) modulators: insights into different protein behaviors with "short" and "long" inverse agonistsMing-Cheng Yu, Feng Yang, Xiao-Yu Ding, et al.
International Journal of Molecular Sciences|September 9, 2022
Computational Pipeline for Reference-Free Comparative Analysis of RNA 3D Structures Applied to SARS-CoV-2 UTR ModelsJulita Gumna, Maciej Antczak, Ryszard W Adamiak, et al.
Journal of Molecular Biology|July 16, 2026
The Advantages of AI for Computational Protein Studies and Looking Ahead at the Next Challenges: Single Structures Are Not EnoughPradeep Bk, Shi-Jie Chen, Ruxandra Dima, et al.
Acta Pharmacologica Sinica|April 14, 2021
P300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisibXiao-Ru Zhou, Xiao Li, Li-Ping Liao, et al.
ACS Applied Bio Materials|June 4, 2024
Cracking the Code: Enhancing Molecular Tools for Progress in NanobiotechnologyYelixza I Avila, Laura P Rebolledo, Elizabeth Skelly, et al.
Pageof 18